English

VYCOR MEDICAL INC

EDGAR

VYCO Quarterly report (10-Q) · filed 2026-08-14

Annual consolidated revenue for 2025: about USD 1.863M, using the latest reported figures. The previous period, 2024, was about USD 1.589M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

418 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 418264 USD Source

Operating margin

1.64%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 6851 USD Source
Revenue: 418264 USD Source

Operating cash flow

-4.84 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 94579 USD Source
Operating Cash Flow: 99422 USD Source

Cash and cash equivalents: 159 thousand USD 2026-06-30 Source
Exact value

158907 USD
Long-term debt including current maturities: Not available
Shares outstanding: 33.4 million shares 2026-06-30 Source
Exact value

33372796 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

33372796 shares · 2025-06-30· Source
33372796 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.81 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 513792 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 1863400 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 1446523 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 458540 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 418264 USD · 2026-04-01 – 2026-06-30 Source

Net income

-59.9 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: 4936 USD · 2025-07-01 – 2025-09-30 Source
Net income: -72426 USD · 2025-01-01 – 2025-12-31 Source
Net income: -9740 USD · 2025-01-01 – 2025-09-30 Source
Net income: 20108 USD · 2026-01-01 – 2026-03-31 Source
Net income: -22288 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

61.4 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -52703 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 19724 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -13471 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -52703 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 99422 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 94579 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 99422 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-14.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.2%

Prior period

USD 1.59 million

2024-01-01 – 2024-12-31
Current period

USD 1.86 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1863400 − 1589324 = 274076 USD

1589324 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1863400 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Year-over-year change in Revenue: 274076 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1863400 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#684528 Filing: 000149315226014036 Input fundies:Revenue: 1589324 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#685000 Filing: 000149315226014036
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 34,774

Prior period

−USD 107,200

2024-01-01 – 2024-12-31
Current period

−USD 72,426

2025-01-01 – 2025-12-31

Exact inputs and evidence

-72426 − -107200 = 34774 USD

-107200 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-72426 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Year-over-year change in Net income: 34774 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -72426 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#490934 Filing: 000149315226014036 Input fundies:NetIncome: -107200 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#491233 Filing: 000149315226014036
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-122.4%

Prior period

USD 60,110

2024-01-01 – 2024-12-31
Current period

−USD 13,471

2025-01-01 – 2025-12-31

Exact inputs and evidence

-13471 − 60110 = -73581 USD

60110 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-13471 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Year-over-year change in Operating cash flow: -73581 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13471 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#467598 Filing: 000149315226014036 Input fundies:OperatingCashFlow: 60110 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#468057 Filing: 000149315226014036
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-2.6%

Prior period

USD 5,366

2024-01-01 – 2024-12-31
Current period

USD 5,224

2025-01-01 – 2025-12-31

Exact inputs and evidence

5224 − 5366 = -142 USD

5366 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
5224 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Year-over-year change in Capital expenditure: -142 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5224 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#469196 Filing: 000149315226014036 Input fundies:CapitalExpenditure: 5366 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#469533 Filing: 000149315226014036
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 1.86 million 100% of revenue
Cost of revenue USD 302,293 16% of revenue
Operating expenses USD 1.53 million 82% of revenue
Operating income USD 33,900 1.8% of revenue
Tax, interest and other Derived USD 106,326 5.7% of revenue
Net income −USD 72,426 −3.9% of revenue

Cash

Operating cash flow −USD 13,471 −0.7% of revenue
Capital expenditure USD 5,224 0.3% of revenue
Free cash flow Derived −USD 18,695 −1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 210% of revenue.
2017 Operating loss: operating costs were 195% of revenue.
2018 Operating loss: operating costs were 187% of revenue.
2019 Operating loss: operating costs were 143% of revenue.
2020 Operating loss: operating costs were 164% of revenue.
2021 Operating loss: operating costs were 131% of revenue.
2022 Operating loss: operating costs were 125% of revenue.
2023 Net loss: net income was −4.8% of revenue.
2024 Operating loss: operating costs were 101% of revenue.
2025 Net loss: net income was −3.9% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1452714	3044092 Derived	-1591378	60902 Derived	-1652280	-554369 Derived	Source 2016-01-01 – 2016-12-31: 1452714 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1591378 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -1652280 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -496918 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 57451 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	1384971	2697534 Derived	-1312563	164482 Derived	-1477045	-710696 Derived	Source 2017-01-01 – 2017-12-31: 1384971 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -1312563 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -1477045 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -527438 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 183258 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1509330	2827065 Derived	-1317735	61621 Derived	-1379356	-323845 Derived	Source 2018-01-01 – 2018-12-31: 1509330 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -1317735 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -1379356 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -260322 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 63523 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	1392900	1994293 Derived	-601393	194809 Derived	-796202	-58924 Derived	Source 2019-01-01 – 2019-12-31: 1392900 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -601393 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -796202 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -6020 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 52904 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1142045	1869439 Derived	-727394	95088 Derived	-822482	-310843 Derived	Source 2020-01-01 – 2020-12-31: 1142045 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -727394 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -822482 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -248791 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 62052 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1392987	1828941 Derived	-435954	-292 Derived	-435662	-17006 Derived	Source 2021-01-01 – 2021-12-31: 1392987 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -435954 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -435662 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 21369 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 38375 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	1222989	1529503 Derived	-306514	98403 Derived	-404917	-219796 Derived	Source 2022-01-01 – 2022-12-31: 1222989 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -306514 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -404917 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -217016 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 2780 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	1460604	1420413 Derived	40191	109882 Derived	-69691	20044 Derived	Source 2023-01-01 – 2023-12-31: 1460604 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 40191 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -69691 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 29430 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 9386 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	1589324	1598469 Derived	-9145	98055 Derived	-107200	54744 Derived	Source 2024-01-01 – 2024-12-31: 1589324 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -9145 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -107200 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 60110 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 5366 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	1863400	1829500 Derived	33900	106326 Derived	-72426	-18695 Derived	Source 2025-01-01 – 2025-12-31: 1863400 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 33900 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -72426 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -13471 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 5224 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.9M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	1452714	Revenue: 1452714 Open source
20172017-12-31	Revenue	1384971	Revenue: 1384971 Open source
20182018-12-31	Revenue	1509330	Revenue: 1509330 Open source
20192019-12-31	Revenue	1392900	Revenue: 1392900 Open source
20202020-12-31	Revenue	1142045	Revenue: 1142045 Open source
20212021-12-31	Revenue	1392987	Revenue: 1392987 Open source
20222022-12-31	Revenue	1222989	Revenue: 1222989 Open source
20232023-12-31	Revenue	1460604	Revenue: 1460604 Open source
20242024-12-31	Revenue	1589324	Revenue: 1589324 Open source
20252025-12-31	Revenue	1863400	Revenue: 1863400 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.2% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	27.6%	Revenue: 1452714 Open source Revenue: 1138634 Open source
20172017-12-31	Year over year	-4.7%	Revenue: 1384971 Open source Revenue: 1452714 Open source
20182018-12-31	Year over year	9%	Revenue: 1509330 Open source Revenue: 1384971 Open source
20192019-12-31	Year over year	-7.7%	Revenue: 1392900 Open source Revenue: 1509330 Open source
20202020-12-31	Year over year	-18%	Revenue: 1142045 Open source Revenue: 1392900 Open source
20212021-12-31	Year over year	22%	Revenue: 1392987 Open source Revenue: 1142045 Open source
20222022-12-31	Year over year	-12.2%	Revenue: 1222989 Open source Revenue: 1392987 Open source
20232023-12-31	Year over year	19.4%	Revenue: 1460604 Open source Revenue: 1222989 Open source
20242024-12-31	Year over year	8.8%	Revenue: 1589324 Open source Revenue: 1460604 Open source
20252025-12-31	Year over year	17.2%	Revenue: 1863400 Open source Revenue: 1589324 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 1.8% 2025

Net margin -3.9% 2025

Free cash flow margin -1% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-109.5%	Operating Income: -1591378 Open source Revenue: 1452714 Open source
20172017-12-31	Operating margin	-94.8%	Operating Income: -1312563 Open source Revenue: 1384971 Open source
20182018-12-31	Operating margin	-87.3%	Operating Income: -1317735 Open source Revenue: 1509330 Open source
20192019-12-31	Operating margin	-43.2%	Operating Income: -601393 Open source Revenue: 1392900 Open source
20202020-12-31	Operating margin	-63.7%	Operating Income: -727394 Open source Revenue: 1142045 Open source
20212021-12-31	Operating margin	-31.3%	Operating Income: -435954 Open source Revenue: 1392987 Open source
20222022-12-31	Operating margin	-25.1%	Operating Income: -306514 Open source Revenue: 1222989 Open source
20232023-12-31	Operating margin	2.8%	Operating Income: 40191 Open source Revenue: 1460604 Open source
20242024-12-31	Operating margin	-0.6%	Operating Income: -9145 Open source Revenue: 1589324 Open source
20252025-12-31	Operating margin	1.8%	Operating Income: 33900 Open source Revenue: 1863400 Open source
20162016-12-31	Net margin	-113.7%	Net Income: -1652280 Open source Revenue: 1452714 Open source
20172017-12-31	Net margin	-106.6%	Net Income: -1477045 Open source Revenue: 1384971 Open source
20182018-12-31	Net margin	-91.4%	Net Income: -1379356 Open source Revenue: 1509330 Open source
20192019-12-31	Net margin	-57.2%	Net Income: -796202 Open source Revenue: 1392900 Open source
20202020-12-31	Net margin	-72%	Net Income: -822482 Open source Revenue: 1142045 Open source
20212021-12-31	Net margin	-31.3%	Net Income: -435662 Open source Revenue: 1392987 Open source
20222022-12-31	Net margin	-33.1%	Net Income: -404917 Open source Revenue: 1222989 Open source
20232023-12-31	Net margin	-4.8%	Net Income: -69691 Open source Revenue: 1460604 Open source
20242024-12-31	Net margin	-6.7%	Net Income: -107200 Open source Revenue: 1589324 Open source
20252025-12-31	Net margin	-3.9%	Net Income: -72426 Open source Revenue: 1863400 Open source
20162016-12-31	Free cash flow margin	-38.2%	Revenue: 1452714 Open source Operating Cash Flow: -496918 Open source Capital Expenditure: 57451 Open source
20172017-12-31	Free cash flow margin	-51.3%	Revenue: 1384971 Open source Operating Cash Flow: -527438 Open source Capital Expenditure: 183258 Open source
20182018-12-31	Free cash flow margin	-21.5%	Revenue: 1509330 Open source Operating Cash Flow: -260322 Open source Capital Expenditure: 63523 Open source
20192019-12-31	Free cash flow margin	-4.2%	Revenue: 1392900 Open source Operating Cash Flow: -6020 Open source Capital Expenditure: 52904 Open source
20202020-12-31	Free cash flow margin	-27.2%	Revenue: 1142045 Open source Operating Cash Flow: -248791 Open source Capital Expenditure: 62052 Open source
20212021-12-31	Free cash flow margin	-1.2%	Revenue: 1392987 Open source Operating Cash Flow: 21369 Open source Capital Expenditure: 38375 Open source
20222022-12-31	Free cash flow margin	-18%	Revenue: 1222989 Open source Operating Cash Flow: -217016 Open source Capital Expenditure: 2780 Open source
20232023-12-31	Free cash flow margin	1.4%	Revenue: 1460604 Open source Operating Cash Flow: 29430 Open source Capital Expenditure: 9386 Open source
20242024-12-31	Free cash flow margin	3.4%	Revenue: 1589324 Open source Operating Cash Flow: 60110 Open source Capital Expenditure: 5366 Open source
20252025-12-31	Free cash flow margin	-1%	Revenue: 1863400 Open source Operating Cash Flow: -13471 Open source Capital Expenditure: 5224 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.5K 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-496918	Operating Cash Flow: -496918 Open source
20172017-12-31	Operating cash flow	-527438	Operating Cash Flow: -527438 Open source
20182018-12-31	Operating cash flow	-260322	Operating Cash Flow: -260322 Open source
20192019-12-31	Operating cash flow	-6020	Operating Cash Flow: -6020 Open source
20202020-12-31	Operating cash flow	-248791	Operating Cash Flow: -248791 Open source
20212021-12-31	Operating cash flow	21369	Operating Cash Flow: 21369 Open source
20222022-12-31	Operating cash flow	-217016	Operating Cash Flow: -217016 Open source
20232023-12-31	Operating cash flow	29430	Operating Cash Flow: 29430 Open source
20242024-12-31	Operating cash flow	60110	Operating Cash Flow: 60110 Open source
20252025-12-31	Operating cash flow	-13471	Operating Cash Flow: -13471 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -18.7K 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-554369	Operating Cash Flow: -496918 Open source Capital Expenditure: 57451 Open source
20172017-12-31	Free cash flow	-710696	Operating Cash Flow: -527438 Open source Capital Expenditure: 183258 Open source
20182018-12-31	Free cash flow	-323845	Operating Cash Flow: -260322 Open source Capital Expenditure: 63523 Open source
20192019-12-31	Free cash flow	-58924	Operating Cash Flow: -6020 Open source Capital Expenditure: 52904 Open source
20202020-12-31	Free cash flow	-310843	Operating Cash Flow: -248791 Open source Capital Expenditure: 62052 Open source
20212021-12-31	Free cash flow	-17006	Operating Cash Flow: 21369 Open source Capital Expenditure: 38375 Open source
20222022-12-31	Free cash flow	-219796	Operating Cash Flow: -217016 Open source Capital Expenditure: 2780 Open source
20232023-12-31	Free cash flow	20044	Operating Cash Flow: 29430 Open source Capital Expenditure: 9386 Open source
20242024-12-31	Free cash flow	54744	Operating Cash Flow: 60110 Open source Capital Expenditure: 5366 Open source
20252025-12-31	Free cash flow	-18695	Operating Cash Flow: -13471 Open source Capital Expenditure: 5224 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

592.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	Total Assets: 1485250 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 1449457 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 1043777 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 1091943 Open source
20202020-12-31	Liabilities / assets	300.8%	Total Liabilities: 2967836 Open source Total Assets: 986520 Open source
20212021-12-31	Liabilities / assets	356.1%	Total Liabilities: 3330577 Open source Total Assets: 935364 Open source
20222022-12-31	Liabilities / assets	441.9%	Total Liabilities: 3801049 Open source Total Assets: 860178 Open source
20232023-12-31	Liabilities / assets	435.1%	Total Liabilities: 4317774 Open source Total Assets: 992298 Open source
20242024-12-31	Liabilities / assets	469.7%	Total Liabilities: 4688200 Open source Total Assets: 998117 Open source
20252025-12-31	Liabilities / assets	592.1%	Total Liabilities: 4917299 Open source Total Assets: 830420 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.12× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	0.36×	Current Assets: 537089 Open source Current Liabilities: 1511688 Open source
20172017-12-31	Current assets / current liabilities	0.44×	Current Assets: 608508 Open source Current Liabilities: 1368015 Open source
20182018-12-31	Current assets / current liabilities	0.35×	Current Assets: 629646 Open source Current Liabilities: 1812604 Open source
20192019-12-31	Current assets / current liabilities	0.27×	Current Assets: 656432 Open source Current Liabilities: 2446406 Open source
20202020-12-31	Current assets / current liabilities	0.17×	Current Assets: 463901 Open source Current Liabilities: 2740828 Open source
20212021-12-31	Current assets / current liabilities	0.15×	Current Assets: 487411 Open source Current Liabilities: 3149997 Open source
20222022-12-31	Current assets / current liabilities	0.14×	Current Assets: 517763 Open source Current Liabilities: 3654796 Open source
20232023-12-31	Current assets / current liabilities	0.14×	Current Assets: 584090 Open source Current Liabilities: 4074487 Open source
20242024-12-31	Current assets / current liabilities	0.14×	Current Assets: 619614 Open source Current Liabilities: 4496543 Open source
20252025-12-31	Current assets / current liabilities	0.12×	Current Assets: 563422 Open source Current Liabilities: 4781468 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 1.65 million Exact value Exact value: -1652280 USD 2016-01-01 – 2016-12-31: -1652280 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2016-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -1652280 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1652280 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315218004220/vyco-20171231.xml#134694 Filing: 000149315218004220 The citation records this snapshot. The page link may show a newer release later.	−USD 496,918 Exact value Exact value: -496918 USD 2016-01-01 – 2016-12-31: -496918 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2016-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -496918 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -496918 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315218004220/vyco-20171231.xml#143096 Filing: 000149315218004220 The citation records this snapshot. The page link may show a newer release later.	USD 57,451 Exact value Exact value: 57451 USD 2016-01-01 – 2016-12-31: 57451 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2016-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 57451 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 57451 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315218004220/vyco-20171231.xml#143463 Filing: 000149315218004220 The citation records this snapshot. The page link may show a newer release later.	−USD 554,369 Calculation and evidence -496918 − 57451 USD Exact free cash flow: -554369 USD 2016-01-01 – 2016-12-31: -496918 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 57451 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2016-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -554369 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -496918 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315218004220/vyco-20171231.xml#143096 Filing: 000149315218004220 Input fundies:CapitalExpenditure: 57451 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315218004220/vyco-20171231.xml#143463 Filing: 000149315218004220 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 1.48 million Exact value Exact value: -1477045 USD 2017-01-01 – 2017-12-31: -1477045 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2017-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -1477045 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1477045 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315219004176/vyco-20181231.xml#147101 Filing: 000149315219004176 The citation records this snapshot. The page link may show a newer release later.	−USD 527,438 Exact value Exact value: -527438 USD 2017-01-01 – 2017-12-31: -527438 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2017-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -527438 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -527438 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315219004176/vyco-20181231.xml#164819 Filing: 000149315219004176 The citation records this snapshot. The page link may show a newer release later.	USD 183,258 Exact value Exact value: 183258 USD 2017-01-01 – 2017-12-31: 183258 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2017-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 183258 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 183258 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315219004176/vyco-20181231.xml#165185 Filing: 000149315219004176 The citation records this snapshot. The page link may show a newer release later.	−USD 710,696 Calculation and evidence -527438 − 183258 USD Exact free cash flow: -710696 USD 2017-01-01 – 2017-12-31: -527438 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 183258 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2017-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -710696 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -527438 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315219004176/vyco-20181231.xml#164819 Filing: 000149315219004176 Input fundies:CapitalExpenditure: 183258 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315219004176/vyco-20181231.xml#165185 Filing: 000149315219004176 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 1.38 million Exact value Exact value: -1379356 USD 2018-01-01 – 2018-12-31: -1379356 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2018-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -1379356 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1379356 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315220004858/vyco-20191231.xml#137355 Filing: 000149315220004858 The citation records this snapshot. The page link may show a newer release later.	−USD 260,322 Exact value Exact value: -260322 USD 2018-01-01 – 2018-12-31: -260322 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2018-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -260322 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -260322 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315220004858/vyco-20191231.xml#156430 Filing: 000149315220004858 The citation records this snapshot. The page link may show a newer release later.	USD 63,523 Exact value Exact value: 63523 USD 2018-01-01 – 2018-12-31: 63523 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2018-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 63523 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63523 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315220004858/vyco-20191231.xml#156796 Filing: 000149315220004858 The citation records this snapshot. The page link may show a newer release later.	−USD 323,845 Calculation and evidence -260322 − 63523 USD Exact free cash flow: -323845 USD 2018-01-01 – 2018-12-31: -260322 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 63523 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2018-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -323845 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -260322 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315220004858/vyco-20191231.xml#156430 Filing: 000149315220004858 Input fundies:CapitalExpenditure: 63523 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315220004858/vyco-20191231.xml#156796 Filing: 000149315220004858 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 796,202 Exact value Exact value: -796202 USD 2019-01-01 – 2019-12-31: -796202 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2019-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -796202 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -796202 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315221007391/vyco-20201231.xml#438858 Filing: 000149315221007391 The citation records this snapshot. The page link may show a newer release later.	−USD 6,020 Exact value Exact value: -6020 USD 2019-01-01 – 2019-12-31: -6020 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2019-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -6020 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6020 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315221007391/vyco-20201231.xml#444330 Filing: 000149315221007391 The citation records this snapshot. The page link may show a newer release later.	USD 52,904 Exact value Exact value: 52904 USD 2019-01-01 – 2019-12-31: 52904 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2019-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 52904 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52904 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315221007391/vyco-20201231.xml#448537 Filing: 000149315221007391 The citation records this snapshot. The page link may show a newer release later.	−USD 58,924 Calculation and evidence -6020 − 52904 USD Exact free cash flow: -58924 USD 2019-01-01 – 2019-12-31: -6020 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 52904 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2019-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -58924 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6020 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315221007391/vyco-20201231.xml#444330 Filing: 000149315221007391 Input fundies:CapitalExpenditure: 52904 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315221007391/vyco-20201231.xml#448537 Filing: 000149315221007391 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 822,482 Exact value Exact value: -822482 USD 2020-01-01 – 2020-12-31: -822482 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2020-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -822482 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -822482 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315222009797/form10-k.htm#989695 Filing: 000149315222009797 The citation records this snapshot. The page link may show a newer release later.	−USD 248,791 Exact value Exact value: -248791 USD 2020-01-01 – 2020-12-31: -248791 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2020-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -248791 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -248791 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315222009797/form10-k.htm#677185 Filing: 000149315222009797 The citation records this snapshot. The page link may show a newer release later.	USD 62,052 Exact value Exact value: 62052 USD 2020-01-01 – 2020-12-31: 62052 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2020-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 62052 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 62052 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315222009797/form10-k.htm#678633 Filing: 000149315222009797 The citation records this snapshot. The page link may show a newer release later.	−USD 310,843 Calculation and evidence -248791 − 62052 USD Exact free cash flow: -310843 USD 2020-01-01 – 2020-12-31: -248791 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 62052 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2020-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -310843 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -248791 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315222009797/form10-k.htm#677185 Filing: 000149315222009797 Input fundies:CapitalExpenditure: 62052 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315222009797/form10-k.htm#678633 Filing: 000149315222009797 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 435,662 Exact value Exact value: -435662 USD 2021-01-01 – 2021-12-31: -435662 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2021-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -435662 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -435662 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315223012257/form10-k.htm#1223886 Filing: 000149315223012257 The citation records this snapshot. The page link may show a newer release later.	USD 21,369 Exact value Exact value: 21369 USD 2021-01-01 – 2021-12-31: 21369 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2021-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: 21369 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21369 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315223012257/form10-k.htm#757359 Filing: 000149315223012257 The citation records this snapshot. The page link may show a newer release later.	USD 38,375 Exact value Exact value: 38375 USD 2021-01-01 – 2021-12-31: 38375 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2021-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 38375 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 38375 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315223012257/form10-k.htm#761393 Filing: 000149315223012257 The citation records this snapshot. The page link may show a newer release later.	−USD 17,006 Calculation and evidence 21369 − 38375 USD Exact free cash flow: -17006 USD 2021-01-01 – 2021-12-31: 21369 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 38375 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2021-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -17006 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21369 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315223012257/form10-k.htm#757359 Filing: 000149315223012257 Input fundies:CapitalExpenditure: 38375 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315223012257/form10-k.htm#761393 Filing: 000149315223012257 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 404,917 Exact value Exact value: -404917 USD 2022-01-01 – 2022-12-31: -404917 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2022-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -404917 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -404917 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315224014837/form10-k.htm#743030 Filing: 000149315224014837 The citation records this snapshot. The page link may show a newer release later.	−USD 217,016 Exact value Exact value: -217016 USD 2022-01-01 – 2022-12-31: -217016 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2022-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -217016 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -217016 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315224014837/form10-k.htm#466975 Filing: 000149315224014837 The citation records this snapshot. The page link may show a newer release later.	USD 2,780 Exact value Exact value: 2780 USD 2022-01-01 – 2022-12-31: 2780 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2022-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 2780 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2780 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315224014837/form10-k.htm#468726 Filing: 000149315224014837 The citation records this snapshot. The page link may show a newer release later.	−USD 219,796 Calculation and evidence -217016 − 2780 USD Exact free cash flow: -219796 USD 2022-01-01 – 2022-12-31: -217016 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 2780 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2022-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -219796 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -217016 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315224014837/form10-k.htm#466975 Filing: 000149315224014837 Input fundies:CapitalExpenditure: 2780 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315224014837/form10-k.htm#468726 Filing: 000149315224014837 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 69,691 Exact value Exact value: -69691 USD 2023-01-01 – 2023-12-31: -69691 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2023-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -69691 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69691 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000164117225004744/form10-k.htm#772280 Filing: 000164117225004744 The citation records this snapshot. The page link may show a newer release later.	USD 29,430 Exact value Exact value: 29430 USD 2023-01-01 – 2023-12-31: 29430 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2023-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: 29430 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 29430 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000164117225004744/form10-k.htm#514499 Filing: 000164117225004744 The citation records this snapshot. The page link may show a newer release later.	USD 9,386 Exact value Exact value: 9386 USD 2023-01-01 – 2023-12-31: 9386 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2023-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 9386 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9386 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000164117225004744/form10-k.htm#516230 Filing: 000164117225004744 The citation records this snapshot. The page link may show a newer release later.	USD 20,044 Calculation and evidence 29430 − 9386 USD Exact free cash flow: 20044 USD 2023-01-01 – 2023-12-31: 29430 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 9386 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2023-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: 20044 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 29430 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000164117225004744/form10-k.htm#514499 Filing: 000164117225004744 Input fundies:CapitalExpenditure: 9386 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000164117225004744/form10-k.htm#516230 Filing: 000164117225004744 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 107,200 Exact value Exact value: -107200 USD 2024-01-01 – 2024-12-31: -107200 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2024-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -107200 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -107200 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#491233 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.	USD 60,110 Exact value Exact value: 60110 USD 2024-01-01 – 2024-12-31: 60110 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2024-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: 60110 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 60110 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#468057 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.	USD 5,366 Exact value Exact value: 5366 USD 2024-01-01 – 2024-12-31: 5366 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2024-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 5366 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5366 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#469533 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.	USD 54,744 Calculation and evidence 60110 − 5366 USD Exact free cash flow: 54744 USD 2024-01-01 – 2024-12-31: 60110 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 5366 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2024-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: 54744 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 60110 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#468057 Filing: 000149315226014036 Input fundies:CapitalExpenditure: 5366 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#469533 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 72,426 Exact value Exact value: -72426 USD 2025-01-01 – 2025-12-31: -72426 USD Inspect Net Income Open source Share or cite Citation for Net Income · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Net Income: -72426 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -72426 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#490934 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.	−USD 13,471 Exact value Exact value: -13471 USD 2025-01-01 – 2025-12-31: -13471 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Operating Cash Flow: -13471 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13471 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#467598 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.	USD 5,224 Exact value Exact value: 5224 USD 2025-01-01 – 2025-12-31: 5224 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Capital Expenditure: 5224 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5224 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#469196 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.	−USD 18,695 Calculation and evidence -13471 − 5224 USD Exact free cash flow: -18695 USD 2025-01-01 – 2025-12-31: -13471 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 5224 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VYCOR MEDICAL INC · 2025-12-31 VYCOR MEDICAL INC (edgar:1424768) Free cash flow: -18695 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1424768?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13471 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#467598 Filing: 000149315226014036 Input fundies:CapitalExpenditure: 5224 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1424768/000149315226014036/form10-k.htm#469196 Filing: 000149315226014036 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 5,357 latest values · 5,357 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001424768, 1424768, VYCO, edgar:1424768, vyco

Also known as VYCOR MEDICAL, INC., VYCOR MEDICAL INC, VYCOR MEDICAL, INC, VYCOR MEDICAL, INC., Vycor Medical Inc

VYCOR MEDICAL INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation